Add BrightSurf on Google Email

Science News for February 25, 2024


3D printed titanium structure shows supernatural strength

Researchers at RMIT University created a 50% stronger titanium lattice cube than the strongest alloy of similar density used in aerospace applications. The material's unique lattice structure design distributes stress evenly, making it suitable for medical devices, aircraft, and rocket parts.

SourceRMIT University·JournalAdvanced Materials·TypeExperimental study·DateFeb 25, 2024

Drug limits dangerous reactions to allergy-triggering foods, Stanford Medicine-led study of kids finds

A Stanford Medicine-led study found that the drug omalizumab can prevent dangerous allergic responses in children with food allergies. The research showed that two-thirds of participants who received the drug safely ate small amounts of their allergy-triggering foods, including peanuts and other common allergens.

SourceStanford Medicine·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateFeb 25, 2024

Energy-saving electrochemical hydrogen production via co-generative strategies in hybrid water electrolysis: Recent advances and perspectives

Hybrid water electrolysis enhances hydrogen production efficiency by substituting oxygen evolution reaction with thermodynamically favorable oxidation processes. This technology also enables purification of industrial wastewater and creation of high-value-added chemicals.

SourceDalian Institute of Chemical Physics, Chinese Academy Sciences·JournalChinese Journal of Catalysis·DateFeb 25, 2024
AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

Predicting immunotherapy success

A subset of blood cells, specifically neutrophils expressing the Ly6Ehi protein, can predict immunotherapy treatment response in cancer patients. This discovery has the potential to improve patient outcomes by enabling more targeted and effective treatments.

SourceTechnion-Israel Institute of Technology·JournalCancer Cell·TypeExperimental study·DateFeb 25, 2024

The year of dragon: revisiting the Dragon King

A team of researchers identified a significant Mw7.5 earthquake in Japan as exhibiting characteristics of a 'seismic dragon king', demonstrating predictability. The study analyzed data from the Japan Meteorological Agency's focal mechanism catalogue using the load-unload response ratio (LURR) method.

SourceKeAi Communications Co., Ltd.·JournalEarthquake Research Advances·TypeCase study·DateFeb 25, 2024

Resistance to social robots futile

The study investigates relationships between customer equity drivers and trust in social robots, finding that effective customer service creates value equity. Businesses can benefit from social robots by enhancing relationship equity and brand equity, leading to greater trust and positive customer experiences. However, the negative asp...

SourceEdith Cowan University·JournalTechnological Forecasting and Social Change·TypeSurvey·DateFeb 25, 2024
Garmin GPSMAP 67i with inReach

Garmin GPSMAP 67i with inReach provides rugged GNSS navigation, satellite messaging, and SOS for backcountry geology and climate field teams.

Drug in OUtMATCH clinical trial FDA-approved for the reduction of allergic reactions from accidental food exposures

A new FDA-approved treatment, omalizumab, has shown promise in reducing allergic reactions in multi-food allergic children and adults. The OUtMATCH clinical trial results indicate that a 16-to-20-week course of the monoclonal antibody increased the tolerance threshold for peanut, tree nuts, egg, milk, and wheat.

SourceUniversity of North Carolina Health Care·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateFeb 25, 2024

Antibody reduces allergic reactions to multiple foods in NIH trial

A monoclonal antibody, omalizumab, increased the tolerance threshold for multiple food allergens, allowing children to consume larger amounts without a reaction. The treatment showed significant benefits in reducing allergic reactions, particularly for peanut and egg, with potential protection against accidental exposure.

SourceNIH/National Institute of Allergy and Infectious Diseases·JournalNew England Journal of Medicine·DateFeb 25, 2024